Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:268-276
Published online before print June 30, 2008, doi: 10.1161/CIRCULATIONAHA.107.762765
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Circulation: July 15, 2008, Volume 118, Number 3
Right arrow All Versions of this Article:
118/3/268    most recent
CIRCULATIONAHA.107.762765v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Danchin, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Danchin, N.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Angioplasty
*Heart Attack
Related Collections
Right arrow Fibrinolysis
Right arrow Catheter-based coronary interventions: stents
Right arrow Acute coronary syndromes
Right arrow Acute myocardial infarction
Right arrowRelated Article

(Circulation. 2008;118:268-276.)
© 2008 American Heart Association, Inc.


Interventional Cardiology

Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Acute Myocardial Infarction

Data From the French Registry on Acute ST-Elevation Myocardial Infarction (FAST-MI)

Nicolas Danchin, MD; Pierre Coste, MD; Jean Ferrières, MD; Philippe-Gabriel Steg, MD; Yves Cottin, MD; Didier Blanchard, MD; Loïc Belle, MD; Bernard Ritz, MD; Gilbert Kirkorian, MD; Michael Angioi, MD; Philippe Sans, MD; Bernard Charbonnier, MD; Hélène Eltchaninoff, MD; Pascal Guéret, MD; Khalife Khalife, MD; Philippe Asseman, MD; Jacques Puel, MD; Patrick Goldstein, MD; Jean-Pierre Cambou, MD; Tabassome Simon, MD, for the FAST-MI Investigators*

From Hôpital Européen Georges Pompidou (N.D.), Assistance publique des hôpitaux de Paris, and Université Paris 5, Paris, France; Centre Hospitalier Universitaire Haut Levesque (P.C.), Bordeaux-Pessac, France; Centre Hospitalier Universitaire Rangueil (J.F., J.P.), Toulouse, France; INSERM U-698 et Centre Hospitalier Bichat-Claude Bernard (P.-G.S.), Paris, France; Centre Hospitalier Universitaire Dijon (Y.C.), Dijon, France; Clinique St Gatien (D.B.), Tours, France; Centre Hospitalier d’Annecy (L.B.), Annecy, France; Centre Hospitalier St Joseph et St Luc (B.R.), Lyon, France; Hôpital Cardio-pneumologique (G.K.), Lyon, France; Centre Hospitalier Universitaire Nancy-Brabois (M.A.), Vandoeuvre-lès-Nancy, France; Hôpital Font Pré (P.S.), Toulon, France; Centre Hospitalier Universitaire Tours (B.C.), Tours, France; Centre Hospitalier Universitaire Rouen (H.E.), Rouen, France; Hôpital Henri Mondor (P. Guéret), Créteil, France; Hôpital Bon Secours (K.K.), Metz, France; Hôpital cardiologique (P.A.), Lille, France; Service d’Aide Médicale Urgente (P. Goldstein), Centre Hospitalier Universitaire Lille, Lille, France; Société Française de Cardiologie (J.-P.C.), Paris, France; and Hôpital St Antoine (T.S.), Assistance publique des hôpitaux de Paris, Unité de Recherche Clinique de L’Est Parisien, Université Pierre et Marie Curie Paris 6, Paris, France.

Correspondence to Nicolas Danchin, MD, Division of Coronary Artery Disease and Intensive Cardiac Care, Hôpital Européen Georges Pompidou, Assistance-Publique des Hôpitaux de Paris and Faculté René Descartes, Université Paris 5, 20 rue Leblanc, 75015 Paris, France. E-mail nicolas.danchin{at}egp.aphp.fr

Received December 27, 2007; accepted May 1, 2008.

Background— Intravenous thrombolysis remains a widely used treatment for ST-elevation myocardial infarction; however, it carries a higher risk of reinfarction than primary PCI (PPCI). There are few data comparing PPCI with thrombolysis followed by routine angiography and PCI. The purpose of the present study was to assess contemporary outcomes in ST-elevation myocardial infarction patients, with specific emphasis on comparing a pharmacoinvasive strategy (thrombolysis followed by routine angiography) with PPCI.

Methods and Results— This nationwide registry in France included 223 centers and 1714 patients over a 1-month period at the end of 2005, with 1-year follow-up. Sixty percent of the patients underwent reperfusion therapy, 33% with PPCI and 29% with intravenous thrombolysis (18% prehospital). At baseline, the Global Registry of Acute Coronary Events score was similar in thrombolysis and PPCI patients. Time to initiation of reperfusion therapy was significantly shorter in thrombolysis than in PPCI (median 130 versus 300 minutes). After thrombolysis, 96% of patients had coronary angiography, and 84% had subsequent PCI (58% within 24 hours). In-hospital mortality was 4.3% for thrombolysis and 5.0% for PPCI. In patients with thrombolysis, 30-day mortality was 9.2% when PCI was not used and 3.9% when PCI was subsequently performed (4.0% if PCI was performed in the same hospital and 3.3% if performed after transfer to another facility). One-year survival was 94% for thrombolysis and 92% for PPCI (P=0.31). After propensity score matching, 1-year survival was 94% and 93%, respectively.

Conclusions— When used early after the onset of symptoms, a pharmacoinvasive strategy that combines thrombolysis with a liberal use of PCI yields early and 1-year survival rates that are comparable to those of PPCI.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 118: 211-212. [Extract] [Full Text]



This article has been cited by other articles:


Home page
NEJMHome page
B. R. Wilsmore, A. D. Wilsmore, H. A. Cooper, P. Bogaty, J. M. Brophy, A. v. t Hof, J. P. Ottervanger, Z. Wang, B. Liang, Q. Mei, et al.
Routine Early Angioplasty after Fibrinolysis
N. Engl. J. Med., October 8, 2009; 361(15): 1507 - 1510.
[Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
N. Danchin
Systems of Care for ST-Segment Elevation Myocardial Infarction: Impact of Different Models on Clinical Outcomes
J. Am. Coll. Cardiol. Intv., October 1, 2009; 2(10): 901 - 908.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Carver, S. Rafelt, A. H. Gershlick, K. L. Fairbrother, S. Hughes, R. Wilcox, and for the REACT Investigators
Longer-Term Follow-Up of Patients Recruited to the REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) Trial.
J. Am. Coll. Cardiol., July 7, 2009; 54(2): 118 - 126.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. Bonnefoy, P. G. Steg, F. Boutitie, P.-Y. Dubien, F. Lapostolle, J. Roncalli, F. Dissait, G. Vanzetto, A. Leizorowicz, G. Kirkorian, et al.
Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up
Eur. Heart J., July 1, 2009; 30(13): 1598 - 1606.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
F. W.A. Verheugt
Routine Angioplasty after Fibrinolysis -- How Early Should "Early" Be?
N. Engl. J. Med., June 25, 2009; 360(26): 2779 - 2781.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The year in interventional cardiology.
J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2080 - 2097.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
N. Danchin, R. Carda, A. Chaib, A. Lepillier, and E. Durand
Optimizing outcomes in patients with STEMI: mortality, bleeding, door-to-balloon times, and guidelines: the approach to regional systems for STEMI care: defining the ideal approach to reperfusion therapy based on recent trials
Eur. Heart J. Suppl., June 1, 2009; 11(suppl_C): C25 - C30.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. W. Armstrong, C. M. Westerhout, and R. C. Welsh
Duration of Symptoms Is the Key Modulator of the Choice of Reperfusion for ST-Elevation Myocardial Infarction
Circulation, March 10, 2009; 119(9): 1293 - 1303.
[Full Text] [PDF]


Home page
Eur Heart JHome page
N. Danchin, E. Durand, and D. Blanchard
Pre-hospital thrombolysis in perspective
Eur. Heart J., December 1, 2008; 29(23): 2835 - 2842.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, V. Falk, G. Filippatos, K. Fox, K. Huber, et al.
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:
Eur. Heart J., December 1, 2008; 29(23): 2909 - 2945.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. M. Antman
Time Is Muscle: Translation Into Practice
J. Am. Coll. Cardiol., October 7, 2008; 52(15): 1216 - 1221.
[Abstract] [Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Reperfusion for ST-Segment-Elevation MI: Survival in the Real World
Journal Watch Cardiology, August 27, 2008; 2008(827): 4 - 4.
[Full Text]


Home page
CirculationHome page
H. D. White
Systems of Care: Need for Hub-and-Spoke Systems for Both Primary and Systematic Percutaneous Coronary Intervention After Fibrinolysis
Circulation, July 15, 2008; 118(3): 219 - 222.
[Full Text] [PDF]